Zobrazeno 1 - 10
of 82
pro vyhledávání: '"F. Gómez Campderá"'
Autor:
D. Jarillo Ibáñez, Ma R. Lázaro de Mercado, C. Vozmediano, J. M. Gómez-Carrasco, J. C. Rodríguez-Pérez, P. Aljama, D. Jarillo, L. Raij, J. Mora-Maciá, Oliet A, A. Pérez-García, Julian Segura, A. Vigil-Medina, Luis M. Ruilope, D. Sánz-Guajardo, R. Romero, L Hortal, P. Gallar, C. Bernis, I. Alvarez-Cantalapiedra, F. García Martín, C. Plaza, F. Gómez Campderá, J.M. Bonet, Juan Luis Garrido, J. Nieto, S García de Vinuesa, S. Soriano, R. Fernández, L. Garcés
Publikováno v:
Journal of Hypertension. 20:729-737
Guidelines recommend lower threshold and goal blood pressure (BP) for patients with proteinuria. BP reduction could be accompanied by a different fall in proteinuria depending of the antihypertensive drug. The objective was to compare proteinuria red
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7cc43a34d05a17a5a74cecb7fbdc190
https://doi.org/10.1097/00004872-200204000-00032
https://doi.org/10.1097/00004872-200204000-00032
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 27(3)
The present study was designed to determine the degree of fulfillment of the therapeutic objectives recommended in the clinical guidelines in patients with chronic kidney disease (CKD) in a nephrology outpatient clinic and the treatment that the pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5985de338b823374631719dfc0a3c165
https://pubmed.ncbi.nlm.nih.gov/17725451
https://pubmed.ncbi.nlm.nih.gov/17725451
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d9f8a78db60dc63cd53649abd94b50b2
https://pubmed.ncbi.nlm.nih.gov/17469429
https://pubmed.ncbi.nlm.nih.gov/17469429
Autor:
L, Orte, F, Gómez-Campderá
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e0e42e66ed44bd732b71c44739cd3c72
https://pubmed.ncbi.nlm.nih.gov/17471617
https://pubmed.ncbi.nlm.nih.gov/17471617
Autor:
P M, Martínez, S, García de Vinuesa, M, Ortega Díaz, M, Goicoechea, F, Gómez Campderá, J, Luño
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 25(6)
Darbepoetin alfa has demonstrated its efficacy when is administered subcutaneously once-weekly and once every 2 weeks as treatment of anemia in patients with chronic kidney disease (CKD). The aim of this study is to assess the efficacy of subcutaneus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd8f91a4eb9ea0263c93292eb5931a60
https://pubmed.ncbi.nlm.nih.gov/16514907
https://pubmed.ncbi.nlm.nih.gov/16514907
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::244448a913c4a5acc2c232206e7d12bd
https://pubmed.ncbi.nlm.nih.gov/16392319
https://pubmed.ncbi.nlm.nih.gov/16392319
Autor:
J, Kanter, M, Puerta Carretero, M, Goicoechea, S, García Devinuesa, F, Gómez-Campderá, J, Luño
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::82e40469dbf0951afc20a6b78fa1cda3
https://pubmed.ncbi.nlm.nih.gov/16392316
https://pubmed.ncbi.nlm.nih.gov/16392316
Autor:
N R, Robles, F, Gómez Campderá, I, Ocón, M, Manjón, L, Pastors, J, Herrera, J, Villatoro, I, Calls, I, Torrijos, I, Rodríguez Villareal, M A, Rodríguez Martínez, M L, Méndez, A, Morey, I, Martínez Fernández, I, Marco, A, Liébana, B, Rincón, F, Tornero
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 25(5)
To evaluate the safety and effectiveness of the alfa-blocker doxazosin GITS in CRF patients.The study recruited 203 CRF patients (creatinine1,4 mg/dl for males, creatinine1,2 mg/dl for females, or creatinine clearance80 ml/min). All patients were rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::53645d4e65460ea5e76a03493a966cde
https://pubmed.ncbi.nlm.nih.gov/16392301
https://pubmed.ncbi.nlm.nih.gov/16392301
Autor:
L M, Orte, F, Gómez-Campderá
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6634cc42cbb667fb19e473aec50611d9
https://pubmed.ncbi.nlm.nih.gov/16392315
https://pubmed.ncbi.nlm.nih.gov/16392315
Autor:
N R, Robles, L, Pastor, M, Manjón, J, Ocón, F, Gómez Campderá, J, Herrera, J, Villatoro, J, Calls, J, Torrijos, I, Rodríguez Villareal, M A, Rodríguez Martínez, M L, Méndez, A, Morey, J, Martínez Fernández, J, Marco, A, Liébana, B, Rincón, F, Tornero
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 24(4)
To evaluate the safe use of a new calcium channel blocker, lercanidipine, in diabetic chronic renal failure (CRF) patients.The study recruited 42 diabetic CRF patients (creatinine1.4 mg/dl for males, creatinine1.2 mg/dl for females, or creatinine cle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95e7a0a5ab48e648c011377829be01d3
https://pubmed.ncbi.nlm.nih.gov/15455493
https://pubmed.ncbi.nlm.nih.gov/15455493